BGMSNasdaqWholesale-Durable Goods, NECFiscal year ends December 31Also trades as BGMSP
Bio Green Med Solution, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.93+0.02 (+2.60%)
Close on Oct 19, 2026
- Market cap
- $5.22M
- P/E (TTM)
- –
- Dividend yield
- –
Bio Green Med Solution, Inc. revenue by segment
By business segment
By product or service
| Revenue | TTM Q4 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| Product Revenue Fire Safety [Member] | $747.00K | – | – | – | – | – | 100.0% | – |
| Clinical Trial Supply [Member] | – | $43.00K | $74.00K | $80.00K | $449.00K | $420.00K | – | – |
By region
From the segment and revenue-disaggregation notes of Bio Green Med Solution's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.